Mirae Asset Global Investments Co., Ltd. Cure Vac N.V. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Cure Vac N.V. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 8,698 shares of CVAC stock, worth $47,578. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,698
Previous 7,507
15.87%
Holding current value
$47,578
Previous $20,000
135.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CVAC
# of Institutions
102Shares Held
14.1MCall Options Held
270KPut Options Held
114K-
Black Rock Inc. New York, NY2.25MShares$12.3 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ1.97MShares$10.8 Million0.58% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.58 Million10.6% of portfolio
-
Qube Research & Technologies LTD London, X01.18MShares$6.47 Million0.01% of portfolio
-
Water Island Capital LLC New York, NY957KShares$5.23 Million1.03% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $1.03B
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...